An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS
Clinical trial NCT06249997 · UNKNOWN
Trial details
- NCT number
- NCT06249997
- Sponsor
- Pharming Technologies B.V.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-03
- Primary completion
- 2025-01-31
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.